News

The placebo-controlled, double-blind Phase 2a study expects to include around 50 patients of age 55-85 who have been diagnosed with mild Alzheimer’s disease. Currently, MSDC-0160 is being examined

Wellstat’s uridine triacetate is indicated as a treatment for accidental exposure to the chemotherapeutic 5-fluorouracil (5-FU). The agreement allows BTG to mark, sell and distribute uridine triacetate in

Genedata Biologics 1.5 simplifies data exchange by providing a collaboration platform for pharmaceutical, biotechnology, and technology companies, contract research organizations (CROs) and academic networks. The platform helps to

Following EC’s approval, the company is now set to launch the spray in September 2011. Developed by Nycomed, Instanyl fentanyl nasal spray will be launched in 50µg, 100µg,

The NDA submission was done on the basis of positive results from different trials which demonstrated that Defibrotide does not appear to increase the risk of complications in

The award has been granted to the Duke Cancer Institute Medicine associate professor Herb Hurwitz. The Duke Cancer Institute plans to commence a Phase 1 clinical trial of

As part of the agreement, Innate Pharma will offer pre-clinical support to Bristol-Myers Squibb. Bristol-Myers Squibb will get exclusive worldwide rights to IPH2102 and related compounds. The agreement

Simplicity EMR is a web-based EMR/EHR software system which is used to record, retrieve, and archive patient medical records instantly, anytime, anywhere. The company has obtained federal government’s

As per the terms of the agreement, Cambrex has sold the development and commercialization rights for the drug products to Tillotts which are based on 5-ASA-based technology. In